ConicMeds Development
Research - Poitiers, Poitou-Charentes, France
ConicMeds Development Employees
ConicMeds Development Details
ConicMeds is a biopharmaceutical company that develops a family of proprietary drug candidates (NanospacersTM) for the treatment of pathologies associated with cellular lipointoxication.Lipointoxications are characterized by an accumulation of saturated fatty acids in the membranes of the cells of our organism, which affects their proper functioning. These diseases include obstructive respiratory diseases, such as Cystic Fibrosis and Chronic Obstructive Pulmonary Diseases (COPD), but also metabolic syndromes, responsible for Type 2 Diabetes, Hepatic Steatosis and certain cardiovascular diseases.The unique mode of action of NanospacersTM provides new therapeutic solutions to meet major public health challenges for which medical needs are not yet satisfied, as evidenced by the very high progression of respiratory and metabolic diseases throughout the world.
ConicMeds Development Technologies
Load Balancers
Nginx